Latest Insider Transactions at Ptc Therapeutics, Inc. (PTCT)
This section provides a real-time view of insider transactions for Ptc Therapeutics, Inc. (PTCT). The data is sourced from Form 4 filings with the SEC, which are filed by insiders of PTC THERAPEUTICS, INC. to disclose their transactions in the company's securities. By reviewing this information, investors can gain insights into the trading activity of PTC THERAPEUTICS, INC.'s insiders and make more informed investment decisions.
Insider Transaction List
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Jan 09
2024
|
Eric Pauwels CHIEF EXECUTIVE OFFICER |
SELL
Open market or private sale
|
Direct |
2,065
-4.43%
|
$59,885
$29.01 P/Share
|
|
Jan 09
2024
|
Neil Gregory Almstead CHIEF TECHNICAL OPS OFFICER |
SELL
Open market or private sale
|
Indirect |
100
-2.61%
|
$2,900
$29.01 P/Share
|
|
Jan 09
2024
|
Neil Gregory Almstead CHIEF TECHNICAL OPS OFFICER |
SELL
Open market or private sale
|
Direct |
1,521
-2.4%
|
$44,109
$29.01 P/Share
|
|
Jan 08
2024
|
Michael Schmertzler |
SELL
Open market or private sale
|
Direct |
1,500
-1.28%
|
$40,500
$27.81 P/Share
|
|
Jan 08
2024
|
Christine Marie Utter SVP, CHIEF ACCOUNTING OFFICER |
SELL
Open market or private sale
|
Direct |
1,188
-3.07%
|
$33,264
$28.64 P/Share
|
|
Jan 08
2024
|
Mark Elliott Boulding EXEC. VP AND CLO |
SELL
Open market or private sale
|
Direct |
1,457
-1.93%
|
$40,796
$28.64 P/Share
|
|
Jan 08
2024
|
Lee Scott Golden EVP & CHIEF MEDICAL OFFICER |
SELL
Open market or private sale
|
Direct |
775
-1.94%
|
$21,700
$28.64 P/Share
|
|
Jan 08
2024
|
Matthew B. Klein CHIEF EXECUTIVE OFFICER |
SELL
Open market or private sale
|
Direct |
2,237
-1.33%
|
$62,636
$28.64 P/Share
|
|
Jan 08
2024
|
Eric Pauwels CHIEF EXECUTIVE OFFICER |
SELL
Open market or private sale
|
Direct |
1,569
-3.26%
|
$43,932
$28.64 P/Share
|
|
Jan 08
2024
|
Neil Gregory Almstead CHIEF TECHNICAL OPS OFFICER |
SELL
Open market or private sale
|
Indirect |
53
-1.36%
|
$1,484
$28.64 P/Share
|
|
Jan 08
2024
|
Neil Gregory Almstead CHIEF TECHNICAL OPS OFFICER |
SELL
Open market or private sale
|
Direct |
1,236
-1.91%
|
$34,608
$28.64 P/Share
|
|
Jan 05
2024
|
Matthew B. Klein CHIEF EXECUTIVE OFFICER |
SELL
Open market or private sale
|
Direct |
10,107
-5.67%
|
$272,889
$27.15 P/Share
|
|
Dec 28
2023
|
Matthew B. Klein CHIEF EXECUTIVE OFFICER |
BUY
Grant, award, or other acquisition
|
Direct |
75,000
+29.65%
|
-
|
|
Dec 12
2023
|
Pierre Gravier CHIEF FINANCIAL OFFICER |
BUY
Open market or private purchase
|
Direct |
7,700
+18.6%
|
$192,500
$25.81 P/Share
|
|
Sep 06
2023
|
Alethia Young |
SELL
Open market or private sale
|
Direct |
11,666
-38.77%
|
$454,974
$39.85 P/Share
|
|
Sep 06
2023
|
Alethia Young |
BUY
Exercise of conversion of derivative security
|
Direct |
11,666
+27.85%
|
$314,982
$27.85 P/Share
|
|
Jul 13
2023
|
Pierre Gravier CHIEF FINANCIAL OFFICER |
BUY
Grant, award, or other acquisition
|
Direct |
26,000
+50.0%
|
-
|
|
Jun 07
2023
|
Michael Schmertzler |
SELL
Open market or private sale
|
Direct |
1,000
-0.85%
|
$44,000
$44.86 P/Share
|
|
Jun 06
2023
|
William F. Bell Jr. |
BUY
Grant, award, or other acquisition
|
Direct |
6,333
+38.46%
|
-
|
|
May 23
2023
|
Emma Reeve |
SELL
Open market or private sale
|
Direct |
2,652
-10.54%
|
$156,468
$59.53 P/Share
|
|
May 23
2023
|
Emma Reeve |
BUY
Exercise of conversion of derivative security
|
Direct |
2,652
+9.25%
|
$87,516
$33.43 P/Share
|
|
May 22
2023
|
Emma Reeve |
SELL
Open market or private sale
|
Direct |
7,116
-22.38%
|
$419,844
$59.53 P/Share
|
|
May 22
2023
|
Emma Reeve |
BUY
Exercise of conversion of derivative security
|
Direct |
7,116
+17.05%
|
$234,828
$33.43 P/Share
|
|
May 22
2023
|
Eric Pauwels CHIEF EXECUTIVE OFFICER |
SELL
Open market or private sale
|
Direct |
2,013
-2.03%
|
$118,767
$59.32 P/Share
|
|
May 19
2023
|
Eric Pauwels CHIEF EXECUTIVE OFFICER |
SELL
Open market or private sale
|
Direct |
6,403
-11.44%
|
$371,374
$58.96 P/Share
|
|
May 18
2023
|
Eric Pauwels CHIEF EXECUTIVE OFFICER |
SELL
Open market or private sale
|
Direct |
788
-1.39%
|
$45,704
$58.71 P/Share
|
|
May 17
2023
|
Eric Pauwels CHIEF EXECUTIVE OFFICER |
SELL
Open market or private sale
|
Direct |
8,048
-6.28%
|
$466,784
$58.51 P/Share
|
|
May 11
2023
|
Allan Steven Jacobson |
SELL
Open market or private sale
|
Direct |
23,000
-26.53%
|
$1,288,000
$56.04 P/Share
|
|
May 11
2023
|
Allan Steven Jacobson |
BUY
Exercise of conversion of derivative security
|
Direct |
23,000
+39.42%
|
$230,000
$10.85 P/Share
|
|
Apr 21
2023
|
Christine Marie Utter SVP, CHIEF ACCOUNTING OFFICER |
SELL
Open market or private sale
|
Direct |
4,692
-3.72%
|
$258,060
$55.26 P/Share
|
|
Apr 21
2023
|
Christine Marie Utter SVP, CHIEF ACCOUNTING OFFICER |
BUY
Exercise of conversion of derivative security
|
Direct |
4,692
+5.1%
|
$154,836
$33.02 P/Share
|
|
Apr 21
2023
|
Emma Reeve |
SELL
Open market or private sale
|
Direct |
4,328
-19.02%
|
$238,040
$55.31 P/Share
|
|
Apr 18
2023
|
Matthew B. Klein CHIEF EXECUTIVE OFFICER |
SELL
Open market or private sale
|
Direct |
1,211
-1.17%
|
$62,972
$52.04 P/Share
|
|
Apr 18
2023
|
Matthew B. Klein CHIEF EXECUTIVE OFFICER |
BUY
Grant, award, or other acquisition
|
Direct |
26,000
+20.02%
|
-
|
|
Apr 18
2023
|
Eric Pauwels CHIEF EXECUTIVE OFFICER |
SELL
Open market or private sale
|
Direct |
732
-1.12%
|
$38,064
$52.04 P/Share
|
|
Apr 17
2023
|
David P Southwell |
SELL
Open market or private sale
|
Direct |
11,429
-30.76%
|
$582,879
$51.06 P/Share
|
|
Apr 17
2023
|
David P Southwell |
BUY
Exercise of conversion of derivative security
|
Direct |
11,429
+34.26%
|
$205,722
$18.01 P/Share
|
|
Apr 17
2023
|
Mark Elliott Boulding EXEC. VP AND CLO |
SELL
Open market or private sale
|
Direct |
61,923
-23.97%
|
$3,158,073
$51.42 P/Share
|
|
Apr 17
2023
|
Mark Elliott Boulding EXEC. VP AND CLO |
BUY
Exercise of conversion of derivative security
|
Direct |
61,923
+17.23%
|
$1,857,690
$30.86 P/Share
|
|
Mar 31
2023
|
David P Southwell |
SELL
Open market or private sale
|
Direct |
2,571
-19.67%
|
$128,550
$50.05 P/Share
|
|
Mar 31
2023
|
David P Southwell |
BUY
Exercise of conversion of derivative security
|
Direct |
2,571
+16.44%
|
$46,278
$18.01 P/Share
|
|
Mar 29
2023
|
Christine Marie Utter SVP, CHIEF ACCOUNTING OFFICER |
SELL
Open market or private sale
|
Direct |
4,688
-5.62%
|
$220,336
$47.79 P/Share
|
|
Mar 29
2023
|
Christine Marie Utter SVP, CHIEF ACCOUNTING OFFICER |
BUY
Exercise of conversion of derivative security
|
Direct |
4,688
+9.88%
|
$187,520
$40.45 P/Share
|
|
Mar 27
2023
|
David P Southwell |
SELL
Open market or private sale
|
Direct |
10,000
-18.91%
|
$450,000
$45.38 P/Share
|
|
Mar 27
2023
|
David P Southwell |
BUY
Exercise of conversion of derivative security
|
Direct |
10,000
+32.79%
|
$270,000
$27.05 P/Share
|
|
Mar 27
2023
|
Christine Marie Utter SVP, CHIEF ACCOUNTING OFFICER |
SELL
Open market or private sale
|
Direct |
26,658
-9.2%
|
$1,199,610
$45.37 P/Share
|
|
Mar 27
2023
|
Christine Marie Utter SVP, CHIEF ACCOUNTING OFFICER |
BUY
Exercise of conversion of derivative security
|
Direct |
26,658
+20.23%
|
$879,714
$33.02 P/Share
|
|
Mar 27
2023
|
Emily Luisa Hill CHIEF FINANCIAL OFFICER |
SELL
Open market or private sale
|
Direct |
7,363
-15.91%
|
$331,335
$45.0 P/Share
|
|
Jan 31
2023
|
Emily Luisa Hill CHIEF FINANCIAL OFFICER |
SELL
Open market or private sale
|
Direct |
575
-1.23%
|
$25,875
$45.63 P/Share
|
|
Jan 31
2023
|
Eric Pauwels CHIEF EXECUTIVE OFFICER |
SELL
Open market or private sale
|
Direct |
375
-0.57%
|
$16,875
$45.63 P/Share
|